Opus Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.21M | Hold |
35,000
| – | – | 2.51% | 13 |
|
|
2025
Q4 | $3.68M | Hold |
35,000
| – | – | 2.24% | 15 |
|
|
2025
Q3 | $2.94M | Hold |
35,000
| – | – | 1.82% | 15 |
|
|
2025
Q2 | $2.77M | Hold |
35,000
| – | – | 1.84% | 16 |
|
|
2025
Q1 | $3.14M | Hold |
35,000
| – | – | 2.24% | 15 |
|
|
2024
Q4 | $3.48M | Hold |
35,000
| – | – | 2.57% | 16 |
|
|
2024
Q3 | $3.97M | Hold |
35,000
| – | – | 2.79% | 16 |
|
|
2024
Q2 | $4.33M | Hold |
35,000
| – | – | 2.8% | 13 |
|
|
2024
Q1 | $4.62M | Hold |
35,000
| – | – | 3.01% | 12 |
|
|
2023
Q4 | $3.82M | Hold |
35,000
| – | – | 2.19% | 19 |
|
|
2023
Q3 | $3.6M | Hold |
35,000
| – | – | 2.22% | 19 |
|
|
2023
Q2 | $4.04M | Hold |
35,000
| – | – | 1.45% | 27 |
|
|
2023
Q1 | $3.72M | Hold |
35,000
| – | – | 1.35% | 28 |
|
|
2022
Q4 | $3.88M | Sell |
35,000
-25,000
| -42% | -$2.56M | 1.38% | 34 |
|
|
2022
Q3 | $5.17M | Hold |
60,000
| – | – | 1.2% | 20 |
|
|
2022
Q2 | $5.47M | Sell |
60,000
-13,400
| -18% | -$1.19M | 1.18% | 22 |
|
|
2022
Q1 | $6.02M | Hold |
73,400
| – | – | 0.93% | 32 |
|
|
2021
Q4 | $5.63M | Sell |
73,400
-3,700
| -5% | -$295K | 0.8% | 32 |
|
|
2021
Q3 | $5.79M | Hold |
77,100
| – | – | 0.89% | 28 |
|
|
2021
Q2 | $6M | Sell |
77,100
-3,701
| -5% | -$275K | 0.9% | 24 |
|
|
2021
Q1 | $5.94M | Hold |
80,801
| – | – | 0.87% | 29 |
|
|
2020
Q4 | $6.31M | Buy |
80,801
+3,878
| +5% | +$297K | 0.99% | 21 |
|
|
2020
Q3 | $6.09M | Hold |
76,923
| – | – | 1.15% | 16 |
|
|
2020
Q2 | $5.68M | Hold |
76,923
| – | – | 1.15% | 16 |
|
|
2020
Q1 | $5.65M | Sell |
76,923
-262
| -0.3% | -$20.6K | 1.19% | 11 |
|
|
2019
Q4 | $6.7M | Hold |
77,185
| – | – | 1.1% | 14 |
|
|
2019
Q3 | $6.2M | Sell |
77,185
-4,978
| -6% | -$399K | 1.08% | 14 |
|
|
2019
Q2 | $6.57M | Hold |
82,163
| – | – | 1.24% | 11 |
|
|
2019
Q1 | $6.52M | Hold |
82,163
| – | – | 1.29% | 10 |
|
|
2018
Q4 | $5.99M | Hold |
82,163
| – | – | 1.29% | 8 |
|
|
2018
Q3 | $5.56M | Sell |
82,163
-20,960
| -20% | -$1.34M | 0.97% | 26 |
|
|
2018
Q2 | $5.97M | Hold |
103,123
| – | – | 1.08% | 15 |
|
|
2018
Q1 | $5.36M | Hold |
103,123
| – | – | 0.98% | 29 |
|
|
2017
Q4 | $5.54M | Hold |
103,123
| – | – | 0.99% | 33 |
|
|
2017
Q3 | $6.3M | Hold |
103,123
| – | – | 1.14% | 16 |
|
|
2017
Q2 | $6.31M | Hold |
103,123
| – | – | 1.07% | 13 |
|
|
2017
Q1 | $6.25M | Hold |
103,123
| – | – | 1.07% | 18 |
|
|
2016
Q4 | $5.79M | Hold |
103,123
| – | – | 1.02% | 26 |
|
|
2016
Q3 | $6.14M | Hold |
103,123
| – | – | 1.04% | 17 |
|
|
2016
Q2 | $5.67M | Buy |
103,123
+15,720
| +18% | +$837K | 1% | 25 |
|
|
2016
Q1 | $4.41M | Buy |
87,403
+19,283
| +28% | +$944K | 0.85% | 33 |
|
|
2015
Q4 | $3.43M | Buy |
68,120
+5,240
| +8% | +$264K | 0.61% | 54 |
|
|
2015
Q3 | $2.96M | Hold |
62,880
| – | – | 0.56% | 60 |
|
|
2015
Q2 | $3.42M | Hold |
62,880
| – | – | 0.62% | 58 |
|
|
2015
Q1 | $3.45M | Sell |
62,880
-15,720
| -20% | -$890K | 0.61% | 51 |
|
|
2014
Q4 | $4.26M | Hold |
78,600
| – | – | 0.76% | 32 |
|
|
2014
Q3 | $4.45M | Hold |
78,600
| – | – | 0.85% | 18 |
|
|
2014
Q2 | $4.34M | Hold |
78,600
| – | – | 0.86% | 32 |
|
|
2014
Q1 | $4.26M | Sell |
78,600
-5,240
| -6% | -$271K | 0.98% | 20 |
|
|
2013
Q4 | $4M | Sell |
83,840
-20,960
| -20% | -$958K | 1.08% | 16 |
|
|
2013
Q3 | $4.76M | Hold |
104,800
| – | – | 1.08% | 11 |
|
|
2013
Q2 | $4.64M | Buy |
+104,800
| New | +$4.68M | 1.11% | 17 |
|
Other funds holding MRK
VCM
VPM
Opus Investment Management's MRK Position: Q1 2026 in Review
Opus Investment Management held its Merck (MRK) position steady in Q1 2026 at 35,000 shares worth $4.21M. The position accounts for 2.51% of the portfolio, ranked #13.
Opus Investment Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.7M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Opus Investment Management held 35,000 shares of Merck worth $4.21M as of Q1 2026.
- Opus Investment Management left its Merck share count unchanged in Q1 2026.
- Merck made up 2.51% of Opus Investment Management's portfolio in Q1 2026, its #13 holding.
- Opus Investment Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Opus Investment Management's Merck position peaked at $6.7M in Q4 2019.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Opus Investment Management's 13F filing for Q1 2026, filed 13 May 2026.